BioStock

Prenumeration

Magle Group on Q2: ”We saw a perfect storm of one-time effects”

2025-08-06 09:02:00

Last Friday, Magle Group published its Q2 report, which showed results below market expectations, impacted by delays in high-value customer orders and raw material shortages. At the same time, the company continues to invest in its core areas – DSM, biopolymers, and stem cell technologies. BioStock invited Aaron Wong, CFO of Magle Group, to the studio to comment on the quarter.

See the interview with Aaron Wong here biostock.se:

https://biostock.se/en/2025/08/magle-group-on-q2-we-saw-a-perfect-storm-of-one-time-effects/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook! 

About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

BioStock

Prenumeration

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden